Amundi’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
Amundi's HALO Position: Q2 2026 in Review
Amundi reduced its Halozyme (HALO) stake by 85% in Q2 2026, selling an estimated $7.04M and leaving 18,349 shares worth $1.44M. The position accounts for ﹤0.01% of the portfolio, ranked #1266.
Amundi first reported a position in HALO in Q2 2021 and has held it in 20 quarters since. The position peaked at $7.86M in Q1 2026. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.
- Amundi held 18,349 shares of Halozyme worth $1.44M as of Q2 2026.
- Amundi sold 103,250 Halozyme shares in Q2 2026, an estimated $7.04M.
- Halozyme made up ﹤0.01% of Amundi's portfolio in Q2 2026, its #1266 holding.
- Amundi first reported a position in Halozyme in Q2 2021 and has held it in 20 quarters since.
- Amundi's Halozyme position peaked at $7.86M in Q1 2026.
- 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.
Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.